Peer-review Policy: The manuscript will be reviewed by two suitable experts in respective subject area. The reports of both the reviewers will be considered when deciding on acceptance/revision or rejection of a manuscript. Editor-In-Chief will make the final decision, based on reviewer’s comments.
Plagiarism Policy: GSC Biological and Pharmaceutical Sciences (GSCBPS) has very strict policy against plagiarism. GSCBPS is strongly against Plagiarism. If claim is proven, then your article will be retracted from the index immediately without notice. The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.
Open access policy: This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
Copyright policy: All the articles published in GSCBPS are distributed under a creative commons license. The journal allows the author(s) to hold the copyright of their work (all usages allowed except for commercial purpose).
Author self-archiving policy: The Journal allows the authors to self-archive pre-print, post-print and publisher’s version of the article in any OAI-compliant repository.
Disclaimer: The author(s) of the articles published in this Journal is/are solely responsible for the content of the article. Neither the GSC Biological and Pharmaceutical Sciences (GSCBPS) nor its editors or publisher or anyone else involved in creating, producing or distribution assumes any liability or responsibility for the accuracy, completeness, or usefulness of any information provided in the Journal, nor shall they be liable for any direct, indirect, incidental, special, consequential or punitive damages arising out of the use of the GSC Biological and Pharmaceutical Sciences (GSCBPS).